SCHEMBL22179997

SCHEMBL22179997

Cc1ncnc2ccc(-c3cc(F)c(NC(=O)N(C)Cc4ccccn4)nc3-c3ccc(F)cc3)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.38
▸ CTNNB1 P35222 1/20 0.38
▸ TCF7L2 Q9NQB0 1/20 0.38
▸ CYP2D6 P10635 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CLK4 Q9HAZ1 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ DYRK1A Q13627 4/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ DHODH Q02127 3/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ TGFBR1 P36897 1/20 0.35
▸ SYK P43405 1/20 0.35
▸ PTGFR P43088 1/20 0.35
▸ GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30738306 1.00 NAMPT (0.38) NAMPTCTNNB1TCF7L2CYP2D6CYP2C19
SCHEMBL22180268 0.88 NAMPT (0.39) NAMPTCTNNB1TCF7L2CYP2D6CYP2C19
SCHEMBL22179704 0.88 ADORA1 (0.39) NAMPTCTNNB1TCF7L2CYP2D6CYP2C19
SCHEMBL28443353 0.83 NAMPT (0.41) NAMPTCTNNB1TCF7L2CYP2D6CYP2C19
SCHEMBL29831787 0.83 NAMPT (0.41) NAMPTCTNNB1TCF7L2CYP2D6CYP2C19
SCHEMBL22179952 0.83 NAMPT (0.41) NAMPTCTNNB1TCF7L2CYP2D6CYP2C19
SCHEMBL22180300 0.75 ALDH1A1 (0.43) CYP2D6CYP2C19CYP1A2CYP3A4CLK4
SCHEMBL30738553 0.75 ALDH1A1 (0.43) CYP2D6CYP2C19CYP1A2CYP3A4CLK4
SCHEMBL22179733 0.75 KMT2A (0.43) NAMPTSMN1; SMN2
SCHEMBL22179990 0.72 ADORA2A (0.38) CLK4DYRK1AALDH1A1PTGFRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166119-B Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-05 — — CN disclosed
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-12-23 — — US disclosed
CN-113166119-A Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-23 — — CN disclosed
WO-2020135210-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2020-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF ADORA2A, ADORA1, ADORA3 NAMPT 169/4885CTNNB1 171/4885TCF7L2 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback